The morphological pathway for mouse forestomach cancer

Oncology Reports

Volumn 15, Issue 2, 2006, Pages 479-483

  Kossoy, George ^a   Ben Hur, Herzl ^b   Elhayany, Asher ^c   Schneider, David F ^d   Zusman, Itshak ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b Kiryat Weitzman   (Israel)

^c CLALIT HEALTH SERVICES   (Israel)

^d ASSAF HAROFEH MEDICAL CENTER   (Israel)

Author keywords

Cancer; Forestomach; Mice

Indexed keywords

7,12 DIMETHYLBENZ[A]ANTHRACENE; CARCINOGEN;

ANIMAL; ARTICLE; CHEMICALLY INDUCED DISORDER; FEMALE; HYPERPLASIA; MOUSE; PATHOLOGY; PRECANCER; SQUAMOUS CELL CARCINOMA; STOMACH TUMOR;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ANIMALS; CARCINOGENS; CARCINOMA, SQUAMOUS CELL; FEMALE; HYPERPLASIA; MICE; PRECANCEROUS CONDITIONS; STOMACH NEOPLASMS;

EID: 33744481330     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.15.2.479     Document Type: Article

References (21)

1. Shabad LM: Methodology of the study of carcinogens in human populations. J Toxicol Environ Health 4: 637-643, 1978.
2. Boorman GA, Wood M and Fukushima S: Tumours of the urinary bladder. IARC Sci Public 111: 383-406, 1994.
3. Finckh ES: Aberrant, variant and deviant differentiation in pathology. Pathology 14: 443-447, 1982.
4. Garcia SB, Park HS, Novelli M and Wright NA: Field cancerization, clonality, and epithelial stem cells: the spread of mutated clones in epithelial sheets. J Pathol 187: 61-81, 1999. (Pubitemid 29009836)
5. Misdraji J and Lauwers GY: Gastric epithelial dysplasia. Semin Diagn Pathol 19: 20-30, 2002. (Pubitemid 34252299)
6. Vindigni B and Galgani P: Gastric dysplasia: classification and clinical characteristics. Minerva Gastroenterol Dietol 50: 331-338, 2004.
7. Krutovskikh VA and Turusov VS: Tumours of the intestines. IARC Sci Publ 111: 195-221, 1994.
8. Yashiro M, Carethers JM, Laghi L, Saito K, Slezak P, Jaramillo E, Rubio C, Koizumi K, Hirakawa K and Boland CR: Genetic pathways in the evolution of morphologically distinct colorectal neoplasms. Cancer Res 61: 2676-2683, 2001. (Pubitemid 32685854)
9. Mueller JD, Bethke B and Stolte M: Colorectal de novo carcinoma: a review of its diagnosis, histopathology, molecular biology, and clinical relevance. Virchows Arch 440: 453-460, 2002. (Pubitemid 34591728)
10. Tahara E: Genetic pathways of two types of gastric cancer. IARC Sci Publ 157: 327-349, 2004.
11. Pozharisski KM: Pathology of tumours in laboratory animals. Tumours of the rat. Tumours of the intestines. IARC Sci Publ 99: 159-198, 1990.
12. Kuramoto S and Oohara T: Minute cancers arising de novo in the human large intestine. Cancer 61: 829-834, 1988. (Pubitemid 18037938)
13. Schlemper RJ, Itabashi M, Kato Y, Lewin KJ, Riddell RH, Shimoda T, Sipponen P, Stolte M and Watanabe H: Differences in the diagnostic criteria used by Japanese and Western pathologists to diagnose colorectal carcinoma. Cancer 82: 60-69, 1998. (Pubitemid 28070480)
14. Kuramoto S and Oohara T: How do colorectal cancers develop? Cancer 75 (suppl 6): 1534-1538, 1995.
15. Nakamura K: De novo cancer and adenoma-carcinoma sequence of the colorectum - clinicopathological differences between de novo carcinoma and carcinoma with the sequence. Nippon Geka Gakkai Zasshi 100: 766-775, 1999.
16. Ponz de Leon M and di Gregorio C: Pathology of colorectal cancer. Dig Liver Dis 33: 372-388, 2001. (Pubitemid 32537027)
17. Endo T, Ookawa K, Tanaka M, Nakaji S, Tsuchida S and Sugawara K: Differences in carcinogenesis by the length of carcinogen exposure period in rat colon. Dig Dis Sci 46: 109-117, 2001. (Pubitemid 32221845)
18. Leininger JR and Jokinen MP: Tumours of the oral cavity, pharynx, oesophagus and stomach. IARC Sci Publ 111: 167-193, 1994.
19. National Toxicology Program: NTP toxicology and carcinogenesis studies of 2,4-hexadienal (89% trans, trans isomer, CAS no. 142-83-6; 11% cis, trans isomer) (Gavages Studies). Natl Toxicol Prog Tech Rep Ser 509: 1-290, 2003.
20. Doi AM, Irwin RD and Bucher JR: Influence of functional group substitutions on the carcinogenicity of anthraquinone in rats and mice: analysis of long-term bioassays by the National Cancer Institute and the National Toxicology Program. J Toxicol Environ Health B Crit Rev 8: 109-126, 2005. (Pubitemid 40364846)
21. Kaneko M, Morimura K, Nishikawa T, Wanibuchi H, Takada N, Osugi H, Kinoshita H and Fukushima S: Different genetic alterations in rat forestomach tumors induced by genotoxic and non-genotoxic carcinogens. Carcinogenesis 23: 1729-1735, 2002. (Pubitemid 35214959)